Enveric Biosciences Inc. (ENVB)
NASDAQ: ENVB
· Real-Time Price · USD
1.16
0.02 (1.75%)
At close: Aug 20, 2025, 3:55 PM
1.19
2.53%
After-hours: Aug 20, 2025, 07:01 PM EDT
Enveric Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 340.38K | 340.38K | 340.38K | 647.09K | 647.09K | 647.09K | 647.09K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.34M | -17.86M | -9.6M |
Cost of Revenue | 376.01K | 420.81K | 425.19K | 339.68K | 350.71K | 380.3K | 408.23K | 413.97K | 439.23K | 410.36K | 400.75K | 507.58K | 560.17K | 648.69K | 681.61K | 47.58M | 54M | 60.26M |
Gross Profit | -35.63K | -80.43K | -84.81K | 307.41K | 296.38K | 266.79K | 238.86K | -413.97K | -439.23K | -410.36K | -400.75K | -507.58K | -560.17K | -648.69K | -681.61K | -73.92M | -71.86M | -69.87M |
Operating Income | -9.96M | -9.34M | -9.63M | -8.84M | -10.21M | -14.07M | -16.45M | -26.32M | -28.53M | -27.48M | -27.42M | -66.14M | -64M | -62.65M | -64.62M | -15.35M | -12.96M | -10.78M |
Interest Income | -225 | -225 | -225 | 566.00 | 2.8K | 3.72K | 3.72K | 3.15K | 916.45 | 0.45 | 0.44 | 0.31 | n/a | n/a | n/a | n/a | 128.84K | 128.84K |
Pretax Income | -9.94M | -9.3M | -9.57M | -9.83M | -10.56M | -15.04M | -17.26M | -24.01M | -23.68M | -20.11M | -19.96M | -59.35M | -59.59M | -57.71M | -56.43M | -9.43M | -7.71M | -8.35M |
Net Income | -9.94M | -9.3M | -9.57M | -9.86M | -10.59M | -15.08M | -17.24M | -27.86M | -24.35M | -18.86M | -18.5M | -46.55M | -49.95M | -49.97M | -48.98M | -9.42M | -7.67M | -8.33M |
Selling & General & Admin | 5.8M | 5.88M | 6.45M | 5.4M | 6.17M | 8.03M | 8.88M | 10.77M | 12.28M | 11.62M | 11.61M | 18.42M | 17.03M | 16.84M | 20.67M | 8.64M | 8.96M | 9.13M |
Research & Development | 3.87M | 3.13M | 2.84M | 3.11M | 3.69M | 5.69M | 7.22M | 7.75M | 8.45M | 8.06M | 8.03M | 8.63M | 7.79M | 6.55M | 4.75M | 2.43M | 1.28M | 446.29K |
Other Expenses | 288.31K | 333.1K | 252.08K | 169.59K | 171.07K | 172.81K | 259.3K | 345.8K | 346.15K | 345.13K | 327.91K | -585.16K | -498.11K | -409.6K | -777.58K | -756.8K | -929.62K | -1.1M |
Operating Expenses | 9.96M | 9.34M | 9.55M | 8.67M | 10.04M | 13.89M | 16.36M | 18.87M | 21.07M | 20.03M | 19.96M | 27.46M | 25.32M | 23.98M | 25.94M | 9.77M | 9.26M | 8.9M |
Interest Expense | -349 | -217 | 479.00 | 479.00 | 2.93K | 2.93K | 2.25K | 2.38K | 454.00 | 1.12K | 5.25K | 10.24K | 10.3K | 14.45K | 10.32K | 5.19K | 133.66K | 179.72K |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.85M | -1.85M | -1.85M | -1.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.02M | 3.78M |
Cost & Expenses | 9.96M | 9.34M | 9.63M | 8.84M | 10.21M | 14.07M | 16.45M | 18.87M | 21.07M | 20.03M | 19.96M | 27.46M | 25.32M | 23.98M | 25.94M | -10.99M | -4.9M | 1.18M |
Income Tax Expense | 7.2K | 7.2K | 8.93K | 24.05K | 17.45K | 17.45K | -44.1K | 3.82M | 662.92K | -1.25M | -1.46M | 23.62M | 26.79M | 28.7M | 28.97M | 1.6M | 1.58M | 1.59M |
Shares Outstanding (Basic) | 2.6M | 1.8K | 502.9K | 580.2K | 2.29M | 4M | 2.53M | 2.53M | 2.53M | 2.53M | 2.53M | 2.53M | 1.05M | 847.13K | 462.86K | 459.29K | 426.67K | 324.41K |
Shares Outstanding (Diluted) | 2.6M | 1.8K | 654.92K | 1.41M | 1.41M | 1.41M | 2.35M | 2.16M | 2.11M | 2.08M | 2.08M | 1.79M | 1.05M | 847.13K | 462.86K | 459.29K | 426.88K | 324.41K |
EPS (Basic) | -1.23K | -1.23K | -10.84 | -6.48 | -4.19 | -6.39 | -8 | -13.3 | -11.73 | -9.55 | -12.34 | -96.55 | -102.73 | -104.02 | -109.03 | -254.75 | -257.04 | -268.78 |
EPS (Diluted) | -1.22K | -1.22K | -9.39 | -6.03 | -5.85 | -7.53 | -8 | -13.3 | -11.62 | -9.44 | -12.23 | -96.44 | -102.73 | -104.02 | -109.03 | -39.98 | -42.27 | -54.01 |
EBITDA | -9.68M | -9.01M | -9.29M | -10.4M | -11.76M | -15.62M | -18M | -23.88M | -26.09M | -23.12M | -22.76M | -62.05M | -59.82M | -57.85M | -56.54M | -11.61M | -8.7M | -8.62M |
EBIT | -9.96M | -9.34M | -9.63M | -9.87M | -11.24M | -15.09M | -17.48M | -24.23M | -26.44M | -23.47M | -23.13M | -62.52M | -59.58M | -57.69M | -56.42M | -9.38M | -7.16M | -7.02M |
Depreciation & Amortization | 288.31K | 333.1K | 337.49K | 339.68K | 350.71K | 380.3K | 408.23K | 413.97K | 439.23K | 410.36K | 400.75K | 507.58K | 560.17K | 648.69K | 681.61K | -1.04M | -661.96K | -302.11K |